Cargando…
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557202/ https://www.ncbi.nlm.nih.gov/pubmed/34718324 http://dx.doi.org/10.1038/s41408-021-00568-3 |
| _version_ | 1784592327108460544 |
|---|---|
| author | Zeidner, Joshua F. Lin, Tara L. Vigil, Carlos E. Fine, Gil Yair Levy, M. Nazha, Aziz Esteve, Jordi Lee, Daniel J. Yee, Karen Dalovisio, Andrew Wang, Eunice S. Bergua Burgues, Juan M. Schriber, Jeffrey Litzow, Mark R. Frankfurt, Olga Castillo, Teresa Bernal Del Bhatt, Vijaya Raj Bhatnagar, Bhavana Mehta, Priyanka Dillon, Richard Vicente, Maria Vidriales Anthony, Stephen Bearss, David Montesinos, Pau Douglas Smith, B. |
| author_facet | Zeidner, Joshua F. Lin, Tara L. Vigil, Carlos E. Fine, Gil Yair Levy, M. Nazha, Aziz Esteve, Jordi Lee, Daniel J. Yee, Karen Dalovisio, Andrew Wang, Eunice S. Bergua Burgues, Juan M. Schriber, Jeffrey Litzow, Mark R. Frankfurt, Olga Castillo, Teresa Bernal Del Bhatt, Vijaya Raj Bhatnagar, Bhavana Mehta, Priyanka Dillon, Richard Vicente, Maria Vidriales Anthony, Stephen Bearss, David Montesinos, Pau Douglas Smith, B. |
| author_sort | Zeidner, Joshua F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8557202 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85572022021-11-15 A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia Zeidner, Joshua F. Lin, Tara L. Vigil, Carlos E. Fine, Gil Yair Levy, M. Nazha, Aziz Esteve, Jordi Lee, Daniel J. Yee, Karen Dalovisio, Andrew Wang, Eunice S. Bergua Burgues, Juan M. Schriber, Jeffrey Litzow, Mark R. Frankfurt, Olga Castillo, Teresa Bernal Del Bhatt, Vijaya Raj Bhatnagar, Bhavana Mehta, Priyanka Dillon, Richard Vicente, Maria Vidriales Anthony, Stephen Bearss, David Montesinos, Pau Douglas Smith, B. Blood Cancer J Correspondence Nature Publishing Group UK 2021-10-30 /pmc/articles/PMC8557202/ /pubmed/34718324 http://dx.doi.org/10.1038/s41408-021-00568-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Zeidner, Joshua F. Lin, Tara L. Vigil, Carlos E. Fine, Gil Yair Levy, M. Nazha, Aziz Esteve, Jordi Lee, Daniel J. Yee, Karen Dalovisio, Andrew Wang, Eunice S. Bergua Burgues, Juan M. Schriber, Jeffrey Litzow, Mark R. Frankfurt, Olga Castillo, Teresa Bernal Del Bhatt, Vijaya Raj Bhatnagar, Bhavana Mehta, Priyanka Dillon, Richard Vicente, Maria Vidriales Anthony, Stephen Bearss, David Montesinos, Pau Douglas Smith, B. A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia |
| title | A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia |
| title_full | A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia |
| title_fullStr | A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia |
| title_full_unstemmed | A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia |
| title_short | A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia |
| title_sort | prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in mcl-1-dependent relapsed/refractory acute myeloid leukemia |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557202/ https://www.ncbi.nlm.nih.gov/pubmed/34718324 http://dx.doi.org/10.1038/s41408-021-00568-3 |
| work_keys_str_mv | AT zeidnerjoshuaf aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT lintaral aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT vigilcarlose aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT finegil aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT yairlevym aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT nazhaaziz aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT estevejordi aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT leedanielj aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT yeekaren aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT dalovisioandrew aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT wangeunices aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT berguaburguesjuanm aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT schriberjeffrey aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT litzowmarkr aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT frankfurtolga aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT castilloteresabernaldel aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT bhattvijayaraj aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT bhatnagarbhavana aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT mehtapriyanka aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT dillonrichard aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT vicentemariavidriales aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT anthonystephen aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT bearssdavid aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT montesinospau aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT douglassmithb aprospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT zeidnerjoshuaf prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT lintaral prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT vigilcarlose prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT finegil prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT yairlevym prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT nazhaaziz prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT estevejordi prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT leedanielj prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT yeekaren prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT dalovisioandrew prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT wangeunices prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT berguaburguesjuanm prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT schriberjeffrey prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT litzowmarkr prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT frankfurtolga prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT castilloteresabernaldel prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT bhattvijayaraj prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT bhatnagarbhavana prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT mehtapriyanka prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT dillonrichard prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT vicentemariavidriales prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT anthonystephen prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT bearssdavid prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT montesinospau prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia AT douglassmithb prospectivebiomarkeranalysisofalvocidibfollowedbycytarabineandmitoxantroneinmcl1dependentrelapsedrefractoryacutemyeloidleukemia |